go to contents

ViraTherapeutics GmbH

Back to list

Facts

Founded
2013
Staff
29
Organization type
RDM biotech/pharma
Region
Tyrol
Focus
human health

Profile

ViraTherapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Our patent protected virus is designed to be safe for human beings and efficiently destroys cancer cells, while leaving normal tissues unharmed. ViraTherapeutics currently performs preclinical safety and efficacy studies for our modified Vesicular Stomatitis Virus (VSV-GP) and aims to conduct first clinical trials in cancer patients in the near future.

Similar companies in RDM biotech/pharma

EVER Neuro Pharma GmbH

Organization type
RDM biotech/pharma
Region
Upper Austria
Focus
human health
Details

Bristol-Myers Squibb GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Biotenzz Gesellschaft für Biotechnologie mbH

Organization type
RDM biotech/pharma
Region
Styria
Focus
industrial processing / environment
Details

ViennaLab Diagnostics GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Contact

Bundesstraße 27
6053 Rum
Tyrol

Contact:
Email: office@viratherapeutics.com
Website